Delivery Order SPE2DB20D6037-SPE2DB25FTVG5

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,780.34 firm fixed-price delivery order is for the supply of 4560062223 - Ondansetron ODT 4 MG Tablet 30S, with a completion date of February 28, 2023. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued up to...
This federal contract award, valued at $21,409.49, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4565095622 - Ondansetron ODT 4 mg Tablet 30s. This award is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, which allows the DLA to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,778.48 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC covers a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,148.15 contract is for the delivery of Ondansetron ODT 4 mg tablets over a period ending on July 18, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders...
This federal contract award, valued at $11,113.92, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The award is a firm fixed-price delivery order for the supply of 4559284509 - Ondansetron ODT 4 MG Tablet 30S, with a completion date of December 2, 2022. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
The federal contract award, valued at $10,374.93, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for 4,566,198,158 units of Ondansetron ODT 4 mg Tablets, with an ultimate completion date of October 25, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $4,007.30 for the purchase of 4,565,213,035 units of Ondansetron HCL 4 mg tablets. The contract has a firm fixed-price pricing type and does not utilize any set-aside designations. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,207.59 firm fixed-price delivery order is for the supply of 4,567,267,129 units of 4 mg Ondansetron HCL tablets. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,736.55, is a firm fixed-price delivery order for the supply of 4566798336 ! ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of December 27, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Ondansetron ODT 4 mg tablets and has a firm fixed price of $2,778.48 with a completion date of July 9, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB25FTVG5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order (SPE2DB20D6037|SPE2DB25FTVG5) with a Firm Fixed Price pricing type, valued at $1,899.39, for the delivery of 4567950272 - Ondansetron ODT 4 mg Tablet 30s. The contract has an ultimate completion date of April 18, 2025 and was awarded on April 17, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. This contract award does not have a set-aside designation.

Generated 7/17/25, 2:32 PM